J Korean Med Assoc.  2017 Jun;60(6):475-483. 10.5124/jkma.2017.60.6.475.

Present state and future of tick-borne infectious diseases in Korea

• Sul H
• Kim DM

• KMID: 2384393
• DOI: http://doi.org/10.5124/jkma.2017.60.6.475

Abstract

The incidence of vector-borne infectious diseases is increasing due to developments in diagnostic techniques, as well as due to economic, environmental, and ecological factors such as global warming, increased rainfall, globalization, and urbanization. Tick-borne infectious diseases occurring in Korea include severe fever with thrombocytopenia syndrome, Lyme disease, anaplasmosis, and Japanese spotted fever. Various skin lesions, such as erythema migrans, tick bite sites, rash, and eschar, are associated with tick-borne infectious diseases. It is necessary to remove ticks immediately to prevent transmission of these tick-borne infectious diseases. Especially for conditions such as Lyme disease, at least 24 to 48 hours of tick attachment to the host is required for transmission of the causative pathogens to the host. Tick-borne diseases are acquired after outdoor activities and have nonspecific symptoms such as fever, headache, and chills, which make them difficult to identify without a diagnostic test. Rapid diagnosis and early treatment can reduce the otherwise significant morbidity and mortality associated with these conditions; therefore, therapy should not be delayed until laboratory confirmation is received.

Keyword

Tick-borne diseases; Scrub typhus; Lyme disease; Rickettsia infections

MeSH Terms

Anaplasmosis
Animals
Asian Continental Ancestry Group
Chills
Communicable Diseases*
Diagnosis
Diagnostic Tests, Routine
Erythema
Exanthema
Fever
Global Warming
Headache
Humans
Incidence
Internationality
Korea*
Lyme Disease
Mortality
Rickettsia Infections
Scrub Typhus
Skin
Thrombocytopenia
Tick Bites
Tick-Borne Diseases
Ticks
Urbanization

Figure

• 

  Figure 1 Incidence of mite and tick-borne diseases reported to Korea Centers for Disease Control and Prevention in South Korea. SFTS, severe fever with thrombocytopenia syndrome.

• 

  Figure 2 (A) Dorsal view of Ixodes nipponensis. (B) Ventral view of I. nipponensis. (C) Dorsal view of Haemaphysalis longicornis. (D) Ventral view of H. longicornis.

Reference

1. National Institute of Meteorological Research. Climate change of Korea: present state and future. Seogwipo: National Institute of Meteorological Research;2009.

2. Kim SH, Jang JY. Correlations between climate change-related infectious diseases and meteorological factors in Korea. J Prev Med Public Health. 2010; 43:436–444.

3. Rossati A. Global warming and its health impact. Int J Occup Environ Med. 2017; 8:7–20.

4. Medlock JM, Leach SA. Effect of climate change on vector-borne disease risk in the UK. Lancet Infect Dis. 2015; 15:721–730.

5. Randolph SE. To what extent has climate change contributed to the recent epidemiology of tick-borne diseases? Vet Parasitol. 2010; 167:92–94.

6. Rudenko N, Golovchenko M, Grubhoffer L, Oliver JH Jr. Updates on Borrelia burgdorferi sensu lato complex with respect to public health. Ticks Tick Borne Dis. 2011; 2:123–128.

7. Noh Y, Kim SY, Lee YS, Kim DW, Kwon T, Hwang KJ. Whole-genome sequence of Borrelia garinii strain 935T isolated from Ixodes persulcatus in South Korea. Genome Announc. 2014; 12. DOI: 10.1128/genomeA.01298-14. [Epub].

8. Picken RN, Strle F, Picken MM, Ruzic-Sabljic E, Maraspin V, Lotric-Furlan S, Cimperman J. Identification of three species of Borrelia burgdorferi sensu lato (B. burgdorferi sensu stricto, B. garinii, and B. afzelii) among isolates from acrodermatitis chronica atrophicans lesions. J Invest Dermatol. 1998; 110:211–214.

9. Shim JC, Youn YH, Kim JR. The investigation of Ixodidae. Rep Natl Inst Health. 1994; 31:149–155.

10. Blaut-Jurkowska J, Olszowska M, Kaznica-Wiatr M, Podolec P. Lyme carditis. Pol Merkur Lekarski. 2015; 39:111–115.

11. Santino I, Longobardi V. Clinical and serological features of patients with suspected Lyme borreliosis. Int J Immunopathol Pharmacol. 2011; 24:797–801.

12. Stanek G, Wormser GP, Gray J, Strle F. Lyme borreliosis. Lancet. 2012; 379:461–473.

13. Stanek G, Strle F. Lyme borreliosis. Lancet. 2003; 362:1639–1647.

14. Sroka-Oleksiak A, Ufir K, Salamon D, Bulanda M, Gosiewski T. Nested-PCR real time as alternative molecular tool for detection of Borrelia burgdorferi compared to the classical serological diagnosis of the blood. Med Dosw Mikrobiol. 2016; 68:47–56.

15. Moore A, Nelson C, Molins C, Mead P, Schriefer M. Current guidelines, common clinical pitfalls, and future directions for laboratory diagnosis of lyme disease, United States. Emerg Infect Dis. 2016; 07. [Epub]. DOI: 10.3201/eid2207.151694.

16. Bleeker-Rovers CP, Vos FJ, de Kleijn EM, Mudde AH, Dofferhoff TS, Richter C, Smilde TJ, Krabbe PF, Oyen WJ, van der Meer JW. A prospective multicenter study on fever of unknown origin: the yield of a structured diagnostic protocol. Medicine (Baltimore). 2007; 86:26–38.

17. Bakken JS, Dumler JS. Clinical diagnosis and treatment of human granulocytotropic anaplasmosis. Ann N Y Acad Sci. 2006; 1078:236–247.

18. Dumler JS, Choi KS, Garcia-Garcia JC, Barat NS, Scorpio DG, Garyu JW, Grab DJ, Bakken JS. Human granulocytic anaplasmosis and Anaplasma phagocytophilum. Emerg Infect Dis. 2005; 11:1828–1834.

19. Chae JS, Yu DH, Shringi S, Klein TA, Kim HC, Chong ST, Lee IY, Foley J. Microbial pathogens in ticks, rodents and a shrew in northern Gyeonggi-do near the DMZ, Korea. J Vet Sci. 2008; 9:285–293.

20. Kang JG, Ko S, Kim YJ, Yang HJ, Lee H, Shin NS, Choi KS, Chae JS. New genetic variants of Anaplasma phagocytophi-lum and Anaplasma bovis from Korean water deer (Hydrop-otes inermis argyropus). Vector Borne Zoonotic Dis. 2011; 11:929–938.

21. Chae JS, Kim CM, Kim EH, Hur EJ, Klein TA, Kang TK, Lee HC, Song JW. Molecular epidemiological study for tick-borne disease (Ehrlichia and Anaplasma spp.) surveillance at selected U.S. military training sites/installations in Korea. Ann N Y Acad Sci. 2003; 990:118–125.

22. Kim CM, Kim MS, Park MS, Park JH, Chae JS. Identification of Ehrlichia chaffeensis, Anaplasma phagocytophilum, and A. bovis in Haemaphysalis longicornis and Ixodes persulcatus ticks from Korea. Vector Borne Zoonotic Dis. 2003; 3:17–26.

23. Kim CM, Yi YH, Yu DH, Lee MJ, Cho MR, Desai AR, Shringi S, Klein TA, Kim HC, Song JW, Baek LJ, Chong ST, O'guinn ML, Lee JS, Lee IY, Park JH, Foley J, Chae JS. Tick-borne rickettsial pathogens in ticks and small mammals in Korea. Appl Environ Microbiol. 2006; 72:5766–5776.

24. Kim KH, Yi J, Oh WS, Kim NH, Choi SJ, Choe PG, Kim NJ, Lee JK, Oh MD. Human granulocytic anaplasmosis, South Korea, 2013. Emerg Infect Dis. 2014; 20:1708–1711.

25. Aguero-Rosenfeld ME, Horowitz HW, Wormser GP, McKenna DF, Nowakowski J, Munoz J, Dumler JS. Human granulocytic ehrlichiosis: a case series from a medical center in New York State. Ann Intern Med. 1996; 125:904–908.

26. Bakken JS, Krueth J, Wilson-Nordskog C, Tilden RL, Asanovich K, Dumler JS. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA. 1996; 275:199–205.

27. Aguero-Rosenfeld ME, Kalantarpour F, Baluch M, Horowitz HW, McKenna DF, Raffalli JT, Hsieh Tc, Wu J, Dumler JS, Wormser GP. Serology of culture-confirmed cases of human granulocytic ehrlichiosis. J Clin Microbiol. 2000; 38:635–638.

28. Bakken JS, Dumler JS, Chen SM, Eckman MR, Van Etta LL, Walker DH. Human granulocytic ehrlichiosis in the upper Midwest United States: a new species emerging? JAMA. 1994; 272:212–218.

29. Parola P, Raoult D. Ticks and tickborne bacterial diseases in humans: an emerging infectious threat. Clin Infect Dis. 2001; 32:897–928.

30. Bakken JS, Dumler JS. Human granulocytic ehrlichiosis. Clin Infect Dis. 2000; 31:554–560.

31. Yu XJ, Liang MF, Zhang SY, Liu Y, Li JD, Sun YL, Zhang L, Zhang QF, Popov VL, Li C, Qu J, Li Q, Zhang YP, Hai R, Wu W, Wang Q, Zhan FX, Wang XJ, Kan B, Wang SW, Wan KL, Jing HQ, Lu JX, Yin WW, Zhou H, Guan XH, Liu JF, Bi ZQ, Liu GH, Ren J, Wang H, Zhao Z, Song JD, He JR, Wan T, Zhang JS, Fu XP, Sun LN, Dong XP, Feng ZJ, Yang WZ, Hong T, Zhang Y, Walker DH, Wang Y, Li DX. Fever with thrombocytopenia associated with a novel bunyavirus in China. N Engl J Med. 2011; 364:1523–1532.

32. Elliott RM. Emerging viruses: the Bunyaviridae. Mol Med. 1997; 3:572–577.

33. Takahashi T, Maeda K, Suzuki T, Ishido A, Shigeoka T, Tominaga T, Kamei T, Honda M, Ninomiya D, Sakai T, Senba T, Kaneyuki S, Sakaguchi S, Satoh A, Hosokawa T, Kawabe Y, Kurihara S, Izumikawa K, Kohno S, Azuma T, Suemori K, Yasukawa M, Mizutani T, Omatsu T, Katayama Y, Miyahara M, Ijuin M, Doi K, Okuda M, Umeki K, Saito T, Fukushima K, Nakajima K, Yoshikawa T, Tani H, Fukushi S, Fukuma A, Ogata M, Shimojima M, Nakajima N, Nagata N, Katano H, Fukumoto H, Sato Y, Hasegawa H, Yamagishi T, Oishi K, Kurane I, Morikawa S, Saijo M. The first identification and retrospective study of severe fever with thrombocytopenia syndrome in Japan. J Infect Dis. 2014; 209:816–827.

34. Kim KH, Yi J, Kim G, Choi SJ, Jun KI, Kim NH, Choe PG, Kim NJ, Lee JK, Oh MD. Severe fever with thrombocytopenia syndrome, South Korea, 2012. Emerg Infect Dis. 2013; 19:1892–1894.

35. Zhang YZ, Zhou DJ, Qin XC, Tian JH, Xiong Y, Wang JB, Chen XP, Gao DY, He YW, Jin D, Sun Q, Guo WP, Wang W, Yu B, Li J, Dai YA, Li W, Peng JS, Zhang GB, Zhang S, Chen XM, Wang Y, Li MH, Lu X, Ye C, de Jong MD, Xu J. The ecology, genetic diversity, and phylogeny of Huaiyangshan virus in China. J Virol. 2012; 86:2864–2868.

36. Xu B, Liu L, Huang X, Ma H, Zhang Y, Du Y, Wang P, Tang X, Wang H, Kang K, Zhang S, Zhao G, Wu W, Yang Y, Chen H, Mu F, Chen W. Metagenomic analysis of fever, thrombocytopenia and leukopenia syndrome (FTLS) in Henan Province, China: discovery of a new bunyavirus. PLoS Pathog. 2011; 7:e1002369.

37. Gai ZT, Zhang Y, Liang MF, Jin C, Zhang S, Zhu CB, Li C, Li XY, Zhang QF, Bian PF, Zhang LH, Wang B, Zhou N, Liu JX, Song XG, Xu A, Bi ZQ, Chen SJ, Li DX. Clinical progress and risk factors for death in severe fever with thrombocytopenia syndrome patients. J Infect Dis. 2012; 206:1095–1102.

38. Choi SJ, Park SW, Bae IG, Kim SH, Ryu SY, Kim HA, Jang HC, Hur J, Jun JB, Jung Y, Chang HH, Kim YK, Yi J, Kim KH, Hwang JH, Kim YS, Jeong HW, Song KH, Park WB, Kim ES, Oh MD. for Korea SFTS Clinical Network. Severe fever with thrombocytopenia syndrome in South Korea, 2013-2015. PLoS Negl Trop Dis. 2016; 10:e0005264.

39. Liu W, Lu QB, Cui N, Li H, Wang LY, Liu K, Yang ZD, Wang BJ, Wang HY, Zhang YY, Zhuang L, Hu CY, Yuan C, Fan XJ, Wang Z, Zhang L, Zhang XA, Walker DH, Cao WC. Case-fatality ratio and effectiveness of ribavirin therapy among hospitalized patients in china who had severe fever with thrombocytopenia syndrome. Clin Infect Dis. 2013; 57:1292–1299.

40. Korea Centers for Disease Control and Prevention. Tick borne infectious disease management guideline. Cheongju: Korea Centers for Disease Control and Prevention;2017.

41. Chung MH, Lee SH, Kim MJ, Lee JH, Kim ES, Kim MK, Park MY, Kang JS. Japanese spotted fever, South Korea. Emerg Infect Dis. 2006; 12:1122–1124.

42. Angelakis E, Richet H, Rolain JM, La Scola B, Raoult D. Comparison of real-time quantitative PCR and culture for the diagnosis of emerging Rickettsioses. PLoS Negl Trop Dis. 2012; 6:e1540.

43. Walker DH, Barbour AG, Oliver JH, Lane RS, Dumler JS, Dennis DT, Persing DH, Azad AF, McSweegan E. Emerging bacterial zoonotic and vector-borne diseases: ecological and epidemiological factors. JAMA. 1996; 275:463–469.

44. Meldrum SC, Birkhead GS, White DJ, Benach JL, Morse DL. Human babesiosis in New York State: an epidemiological des-cription of 136 cases. Clin Infect Dis. 1992; 15:1019–1023.

45. Belman AL. Tick-borne diseases. Semin Pediatr Neurol. 1999; 6:249–266.

46. Spach DH, Liles WC, Campbell GL, Quick RE, Anderson DE Jr, Fritsche TR. Tick-borne diseases in the United States. N Engl J Med. 1993; 329:936–947.

47. Choi E, Pyzocha NJ, Maurer DM. Tick-borne illnesses. Curr Sports Med Rep. 2016; 15:98–104.

48. Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, Krause PJ, Bakken JS, Strle F, Stanek G, Bockenstedt L, Fish D, Dumler JS, Nadelman RB. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006; 43:1089–1134.